Figure 1: The structure of antibody–drug conjugate comprises three parts; namely the monoclonal antibody (giving rise to the drugs specificity), the cytotoxic “payload” (for increased potency compared to unconjugated monoclonal antibody), and a linker molecule that attaches these two units